Laboratory Corporation of America Holdings (LH)

220,68 +0,90 (+0,41 %) À la clôture : 04:00PM EDT

Laboratory Corporation of America Holdings

358 South Main Street
Burlington, NC 27215
United States
336 229 1127
https://www.labcorp.com

Secteur(s): Healthcare
Secteur d’activité: Diagnostics & Research
Employés à temps plein: 70 400

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Adam H. Schechter	Pres, CEO & Chairman	5,51M	S.O.	1965
Mr. Glenn A. Eisenberg	CFO & Exec. VP	2,3M	S.O.	1961
Dr. Brian J. Caveney M.P.H., M.D., J.D., MPH	Exec. VP, Pres of Diagnostics & Chief Medical Officer	1,57M	S.O.	1974
Mr. Mark S. Schroeder	Exec. VP and Pres of Diagnostics Laboratory Operations & Global Supply Chain	1,59M	S.O.	1961
Dr. Paul R. Kirchgraber M.D.	Exec. VP and CEO of Early Devel., Central Laboratories & Global Oncology Bus.es	2,02M	S.O.	1963
Dr. Michelle Abelson Ph.D.	Laboratory Director of Operations	S.O.	S.O.	S.O.
Mr. Peter J. Wilkinson	Sr. VP & Chief Accounting Officer	S.O.	S.O.	1972
Mr. Lance V. Berberian	Exec. VP and Chief Information & Technology Officer	S.O.	S.O.	1963
Dr. Marcia T. Eisenberg Ph.D.	Chief Scientific Officer & Sr. VP	S.O.	S.O.	1960
Chas Cook	VP of Investor Relations	S.O.	S.O.	S.O.

Les montants ont été établis en date du 31 décembre 2021 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications to enable patients to check test results; and online applications for MCOs and accountable care organizations; and end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves MCOs, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Laboratory Corporation of America Holdings en date du 1 mars 2023 est 1. Les scores principaux sont Audit : 4; Société : 7; Droits des actionnaires : 1; Compensation : 1.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.